Shares of AtriCure Inc. (ATRC) have plummeted a staggering 63% from their 52-week high of $59.61, reached in July of last year, and currently trade around the $21 level.
This medical device company offers surgical treatments and therapies for atrial fibrillation (Afib) and reduction of Afib related complications. Isolator Synergy Ablation System, AtriClip Left Atrial Appendage Exclusion System products, EPi-Sense Systems for Hybrid AF Therapy and cryoICE cryoSPHERE probe are some of the company's marketed products.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.